B&G FOODS INC (BGS)

US05508R1068 - Common Stock

8.53  +0.18 (+2.16%)

After market: 8.53 0 (0%)

Fundamental Rating

4

Taking everything into account, BGS scores 4 out of 10 in our fundamental rating. BGS was compared to 92 industry peers in the Food Products industry. BGS has a medium profitability rating, but doesn't score so well on its financial health evaluation. BGS has a bad growth rate and is valued cheaply.



5

1. Profitability

1.1 Basic Checks

In the past year BGS was profitable.
BGS had a positive operating cash flow in the past year.
In multiple years BGS reported negative net income over the last 5 years.
BGS had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -3.27%, BGS is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
The Return On Equity of BGS (-14.05%) is worse than 65.93% of its industry peers.
BGS has a Return On Invested Capital of 8.72%. This is amongst the best in the industry. BGS outperforms 82.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BGS is below the industry average of 8.76%.
The 3 year average ROIC (5.03%) for BGS is below the current ROIC(8.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.27%
ROE -14.05%
ROIC 8.72%
ROA(3y)-0.15%
ROA(5y)1.08%
ROE(3y)-0.64%
ROE(5y)4.67%
ROIC(3y)5.03%
ROIC(5y)5.33%

1.3 Margins

Looking at the Operating Margin, with a value of 16.98%, BGS belongs to the top of the industry, outperforming 91.21% of the companies in the same industry.
BGS's Operating Margin has improved in the last couple of years.
The Gross Margin of BGS (22.22%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BGS has remained more or less at the same level.
Industry RankSector Rank
OM 16.98%
PM (TTM) N/A
GM 22.22%
OM growth 3Y-6.24%
OM growth 5Y3.76%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.37%
GM growth 5Y1.45%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BGS is still creating some value.
The number of shares outstanding for BGS has been increased compared to 1 year ago.
The number of shares outstanding for BGS has been increased compared to 5 years ago.
The debt/assets ratio for BGS has been reduced compared to a year ago.

2.2 Solvency

BGS has an Altman-Z score of 1.60. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.60, BGS is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
BGS has a debt to FCF ratio of 11.10. This is a negative value and a sign of low solvency as BGS would need 11.10 years to pay back of all of its debts.
The Debt to FCF ratio of BGS (11.10) is comparable to the rest of the industry.
BGS has a Debt/Equity ratio of 2.58. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BGS (2.58) is worse than 87.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.58
Debt/FCF 11.1
Altman-Z 1.6
ROIC/WACC1.3
WACC6.71%

2.3 Liquidity

A Current Ratio of 3.22 indicates that BGS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.22, BGS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
A Quick Ratio of 0.92 indicates that BGS may have some problems paying its short term obligations.
The Quick ratio of BGS (0.92) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 0.92

2

3. Growth

3.1 Past

The earnings per share for BGS have decreased strongly by -14.29% in the last year.
Measured over the past years, BGS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.66% on average per year.
The Revenue has decreased by -5.45% in the past year.
The Revenue has been growing slightly by 3.93% on average over the past years.
EPS 1Y (TTM)-14.29%
EPS 3Y-24.05%
EPS 5Y-11.66%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-5.45%
Revenue growth 3Y1.57%
Revenue growth 5Y3.93%
Sales Q2Q%-7.15%

3.2 Future

The Earnings Per Share is expected to grow by 3.82% on average over the next years.
The Revenue is expected to decrease by -0.91% on average over the next years.
EPS Next Y-15.96%
EPS Next 2Y-4.93%
EPS Next 3Y3.82%
EPS Next 5YN/A
Revenue Next Year-4.53%
Revenue Next 2Y-1.92%
Revenue Next 3Y-0.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

BGS is valuated reasonably with a Price/Earnings ratio of 9.48.
Compared to the rest of the industry, the Price/Earnings ratio of BGS indicates a rather cheap valuation: BGS is cheaper than 92.31% of the companies listed in the same industry.
BGS is valuated cheaply when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.53, the valuation of BGS can be described as very reasonable.
Based on the Price/Forward Earnings ratio, BGS is valued cheaper than 94.51% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BGS to the average of the S&P500 Index (20.59), we can say BGS is valued rather cheaply.
Industry RankSector Rank
PE 9.48
Fwd PE 9.53

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BGS is valued cheaper than 87.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BGS is valued cheaper than 94.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.67
EV/EBITDA 6.43

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.93%
EPS Next 3Y3.82%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.90%, BGS is a good candidate for dividend investing.
In the last 3 months the price of BGS has falen by -22.88%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
BGS's Dividend Yield is rather good when compared to the industry average which is at 3.74. BGS pays more dividend than 98.90% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, BGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.9%

5.2 History

The dividend of BGS decreases each year by -11.46%.
BGS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-11.46%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of BGS are negative and hence is the payout ratio. BGS will probably not be able to sustain this dividend level.
DP-52.25%
EPS Next 2Y-4.93%
EPS Next 3Y3.82%

B&G FOODS INC

NYSE:BGS (7/26/2024, 7:18:55 PM)

After market: 8.53 0 (0%)

8.53

+0.18 (+2.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap674.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 8.9%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.48
Fwd PE 9.53
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.27%
ROE -14.05%
ROCE
ROIC
ROICexc
ROICexgc
OM 16.98%
PM (TTM) N/A
GM 22.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 2.58
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.22
Quick Ratio 0.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3Y-24.05%
EPS 5Y
EPS Q2Q%
EPS Next Y-15.96%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.45%
Revenue growth 3Y1.57%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y